St. Vincent Charity Medical Center in Ohio, Biomedical Group Form Innovation Partnership

St. Vincent Charity Medical Center in Cleveland and the Austen BioInnovation Institute in Akron (Ohio) announced a strategic innovation partnership to help surgeons develop and commercialize new solutions.

Advertisement

Through the partnership, surgeons at the hospital, which is part of Cleveland-based Sisters of Charity Health System, will have access to engineering and technology development resources to create medical devices and solutions.

ABIA’s biomedical engineers and St. Vincent surgeons will work together to identify unmet clinical needs and problems that present opportunities for new products. ABIA will then provide market and intellectual property analysis, regulatory strategy, engineering design, prototype development and testing to help commercialize new solutions, according to the news release.

The ABIA Strategic Innovation Partnership will initially focus on orthopedics, according to the release.

More Articles on Healthcare Innovation:

Innovating for Impact: 4 Stages for Creating Value in Healthcare
Fear of Failure Stymies Innovation: Having the Courage to Reimagine Healthcare

CMS’ Innovation Center Uses Rapid-Cycle Approach to Test New Healthcare Models

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.